Indonesia vs Mexico: Cause of death, by non-communicable diseases, female
Indonesia
57.9%
in 2021
Mexico
59.5%
in 2021
Indonesia rank
125th
Mexico rank
124th
Cause of death, by non-communicable diseases, female over time
- Indonesia
- Mexico
How they compare
Mexico currently reports 59.5% against 57.9% in Indonesia, a difference of 1.6%.
The two have swapped places 2 times across 6 shared years of data; in 2000 it was Mexico ahead.
Indonesia ranks 125th and Mexico ranks 124th of 185 countries.
Across the 3 decades both report, Indonesia averaged higher in 1 and Mexico in 2.
Head to head by decade
| Decade | Indonesia | Mexico | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 65.2% | 76.2% | 11.1% | Mexico |
| 2010s | 77.7% | 84.1% | 6.4% | Mexico |
| 2020s | 63.2% | 60.8% | 2.4% | Indonesia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cause of death, by non-communicable diseases, female, Indonesia or Mexico?
- Mexico, at 59.5% against 57.9% in Indonesia as of 2021.
- What is the difference in cause of death, by non-communicable diseases, female between Indonesia and Mexico?
- 1.6%, with Mexico ahead.
- How many years of comparable data are there for Indonesia and Mexico?
- 6 years are reported by both, from 2000 to 2021.
- How do Indonesia and Mexico rank globally for cause of death, by non-communicable diseases, female?
- Indonesia ranks 125th and Mexico ranks 124th of 185 countries.
- Where does this data come from?
- Global Health Estimates, World Health Organization (WHO), published as Cause of death, by non-communicable diseases, female (% of total female deaths). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of female deaths due to non-communicable diseases divided by number of all female deaths, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.